Validation of FRAX® WHO Fracture Risk Assessment Tool with and without the Alara Metriscan Phalangeal Densitometer as a Screening Tool to Identify Osteoporosis in Thai Postmenopausal Women

Objective: To compare the performance of the WHO fracture risk assessment FRAX® tool and Alara Metriscan for screening osteoporosis in elderly Thai women using spine and hip BMD measurement by DXA.Materials and Methods: This study included postmenopausal Thai women, aged between 50 and 90 years,...

Full description

Bibliographic Details
Main Author: Surakit Yingyuenyong
Format: Article
Language:English
Published: The Royal Thai College of Obstetricians and Gynaecologists 2012-09-01
Series:Thai Journal of Obstetrics and Gynaecology
Subjects:
Online Access:https://tci-thaijo.org/index.php/tjog/article/download/3057/2823/
id doaj-786d675ac60d45d3a7f1a69429cea562
record_format Article
spelling doaj-786d675ac60d45d3a7f1a69429cea5622020-11-25T00:29:28ZengThe Royal Thai College of Obstetricians and GynaecologistsThai Journal of Obstetrics and Gynaecology0857-60840857-60842012-09-01203111120Validation of FRAX® WHO Fracture Risk Assessment Tool with and without the Alara Metriscan Phalangeal Densitometer as a Screening Tool to Identify Osteoporosis in Thai Postmenopausal WomenSurakit Yingyuenyong0Banpho Hospital, Banpho, Chachoengsao, ThailandObjective: To compare the performance of the WHO fracture risk assessment FRAX® tool and Alara Metriscan for screening osteoporosis in elderly Thai women using spine and hip BMD measurement by DXA.Materials and Methods: This study included postmenopausal Thai women, aged between 50 and 90 years, who came to check for osteoporosis at Banpho Hospital. Those met at least one of the criteria for routine axial densitometry according to the Thai Osteoporosis Foundation (TOPF) were recruited. The correlation between the FRAX® tool and Alara Metriscan, or FRAX® tool combined with Alara Metriscan classification and the actual BMD-based classification (by DXA) are summarized. Receiver operating characteristic (ROC) curves were constructed for FRAX®tool and Alara Metriscan.Results: This study included 438 postmenopausal Thai women, of whom 122 (27.9%) had osteoporosis. The mean±SD of age, body mass index were 66.4±10.6 years, 23.3±.3.5 kg/m2, respectively. The sensitivity of FRAX® and Alara Metriscan to identify osteoporosis were high (83.6% and 96.7% respectively) but the specificity (72.1%) and PPV (53.6%) of FRAX® were better. However, there is no difference in the AUCs Standard error (SE) of FRAX® (0.857(0.021)) and the AUCs (SE) of Alara metriscan (0.861(0.019)). The combination of FRAX® and Alara Metriscan had lower sensitivity (81.9%) but high specificity (79.4%) to identify women with osteoporosis. When combined FRAX® with Alara Metriscan the LR+ was 3.98 (95%CI :3.16-5.03) and LR- was 0.23 (95%CI:0.15-0.33).Conclusions: FRAX® WHO Fracture Risk Assessment Tool and Alara Metriscan may be helpful to identify women at risk of osteoporosis. Combination of both tools were significantly improve the screening of osteoporosis in postmenopausal Thai women.https://tci-thaijo.org/index.php/tjog/article/download/3057/2823/postmenopausal osteoporosisFRAXradiographic absorptiometrybone densityalara metriscan
collection DOAJ
language English
format Article
sources DOAJ
author Surakit Yingyuenyong
spellingShingle Surakit Yingyuenyong
Validation of FRAX® WHO Fracture Risk Assessment Tool with and without the Alara Metriscan Phalangeal Densitometer as a Screening Tool to Identify Osteoporosis in Thai Postmenopausal Women
Thai Journal of Obstetrics and Gynaecology
postmenopausal osteoporosis
FRAX
radiographic absorptiometry
bone density
alara metriscan
author_facet Surakit Yingyuenyong
author_sort Surakit Yingyuenyong
title Validation of FRAX® WHO Fracture Risk Assessment Tool with and without the Alara Metriscan Phalangeal Densitometer as a Screening Tool to Identify Osteoporosis in Thai Postmenopausal Women
title_short Validation of FRAX® WHO Fracture Risk Assessment Tool with and without the Alara Metriscan Phalangeal Densitometer as a Screening Tool to Identify Osteoporosis in Thai Postmenopausal Women
title_full Validation of FRAX® WHO Fracture Risk Assessment Tool with and without the Alara Metriscan Phalangeal Densitometer as a Screening Tool to Identify Osteoporosis in Thai Postmenopausal Women
title_fullStr Validation of FRAX® WHO Fracture Risk Assessment Tool with and without the Alara Metriscan Phalangeal Densitometer as a Screening Tool to Identify Osteoporosis in Thai Postmenopausal Women
title_full_unstemmed Validation of FRAX® WHO Fracture Risk Assessment Tool with and without the Alara Metriscan Phalangeal Densitometer as a Screening Tool to Identify Osteoporosis in Thai Postmenopausal Women
title_sort validation of frax® who fracture risk assessment tool with and without the alara metriscan phalangeal densitometer as a screening tool to identify osteoporosis in thai postmenopausal women
publisher The Royal Thai College of Obstetricians and Gynaecologists
series Thai Journal of Obstetrics and Gynaecology
issn 0857-6084
0857-6084
publishDate 2012-09-01
description Objective: To compare the performance of the WHO fracture risk assessment FRAX® tool and Alara Metriscan for screening osteoporosis in elderly Thai women using spine and hip BMD measurement by DXA.Materials and Methods: This study included postmenopausal Thai women, aged between 50 and 90 years, who came to check for osteoporosis at Banpho Hospital. Those met at least one of the criteria for routine axial densitometry according to the Thai Osteoporosis Foundation (TOPF) were recruited. The correlation between the FRAX® tool and Alara Metriscan, or FRAX® tool combined with Alara Metriscan classification and the actual BMD-based classification (by DXA) are summarized. Receiver operating characteristic (ROC) curves were constructed for FRAX®tool and Alara Metriscan.Results: This study included 438 postmenopausal Thai women, of whom 122 (27.9%) had osteoporosis. The mean±SD of age, body mass index were 66.4±10.6 years, 23.3±.3.5 kg/m2, respectively. The sensitivity of FRAX® and Alara Metriscan to identify osteoporosis were high (83.6% and 96.7% respectively) but the specificity (72.1%) and PPV (53.6%) of FRAX® were better. However, there is no difference in the AUCs Standard error (SE) of FRAX® (0.857(0.021)) and the AUCs (SE) of Alara metriscan (0.861(0.019)). The combination of FRAX® and Alara Metriscan had lower sensitivity (81.9%) but high specificity (79.4%) to identify women with osteoporosis. When combined FRAX® with Alara Metriscan the LR+ was 3.98 (95%CI :3.16-5.03) and LR- was 0.23 (95%CI:0.15-0.33).Conclusions: FRAX® WHO Fracture Risk Assessment Tool and Alara Metriscan may be helpful to identify women at risk of osteoporosis. Combination of both tools were significantly improve the screening of osteoporosis in postmenopausal Thai women.
topic postmenopausal osteoporosis
FRAX
radiographic absorptiometry
bone density
alara metriscan
url https://tci-thaijo.org/index.php/tjog/article/download/3057/2823/
work_keys_str_mv AT surakityingyuenyong validationoffraxwhofractureriskassessmenttoolwithandwithoutthealarametriscanphalangealdensitometerasascreeningtooltoidentifyosteoporosisinthaipostmenopausalwomen
_version_ 1725331066813677568